Ocugen Inc (OCGN): Next-Year EPS Estimate 101.48%
As of 2026-06-04, Ocugen Inc (OCGN) has a next-year EPS growth estimate of 101.48%.
On 2026-05-27, analyst consensus for OCGN's next-year EPS growth shifted from 103.69% to 101.48% — a negative change of 2.21 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 1.86%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 101.48%
- EPS growth this year
- 1.86%
- EPS next quarter (est)
- -$0.05
- Last price
- $1.37
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 101.48% | 1.86% | -$0.05 | $1.37 |
| 2026-06-03 | 101.48% | 1.86% | -$0.05 | $1.30 |
| 2026-06-02 | 101.48% | 1.86% | -$0.05 | $1.34 |
| 2026-06-01 | 101.48% | 1.86% | -$0.05 | $1.37 |
| 2026-05-31 | 101.48% | 1.86% | -$0.05 | $1.38 |
| 2026-05-28 | 101.48% | 1.86% | -$0.05 | $1.41 |
| 2026-05-27 | 101.48% | 1.86% | -$0.05 | $1.38 |
| 2026-05-26 | 103.69% | 1.86% | -$0.05 | $1.34 |
| 2026-05-25 | 103.74% | 3.11% | -$0.05 | $1.34 |
| 2026-05-24 | 103.74% | 3.11% | -$0.05 | $1.34 |
| 2026-05-21 | 103.74% | 3.11% | -$0.05 | $1.35 |
| 2026-05-20 | 103.74% | 3.11% | -$0.05 | $1.36 |
| 2026-05-19 | 103.74% | 3.11% | -$0.05 | $1.30 |
| 2026-05-18 | 103.74% | 3.11% | -$0.05 | $1.34 |
| 2026-05-17 | 103.74% | 3.11% | -$0.05 | $1.39 |
| 2026-05-14 | 103.74% | 3.11% | -$0.05 | $1.46 |
| 2026-05-13 | 103.74% | 3.11% | -$0.05 | $1.47 |
| 2026-05-12 | 103.74% | 3.11% | -$0.05 | $1.47 |
| 2026-05-11 | 103.74% | 3.11% | -$0.05 | $1.48 |
| 2026-05-10 | 110.04% | 6.21% | -$0.05 | $1.51 |
| 2026-05-07 | 110.04% | 6.21% | -$0.05 | $1.44 |
| 2026-05-06 | 141.22% | 6.83% | -$0.05 | $1.46 |
| 2026-05-05 | 125.76% | 4.35% | -$0.05 | $1.49 |
| 2026-05-04 | 126.10% | 5.59% | -$0.05 | $1.85 |
| 2026-05-03 | 126.10% | 5.59% | -$0.05 | $1.80 |
| 2026-04-30 | 126.10% | 5.59% | -$0.05 | $1.73 |
| 2026-04-29 | 126.10% | 5.59% | -$0.05 | $1.68 |
| 2026-04-28 | 126.10% | 5.59% | -$0.05 | $1.66 |
| 2026-04-27 | 126.10% | 5.59% | -$0.05 | $1.70 |
| 2026-04-26 | 126.10% | 5.59% | -$0.05 | $1.66 |
Recent News
- Ocugens GA gene therapy garners mixed sentiments on 12-month Phase II readoutClinical Trials Arena
- Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa Clinical Trial Evaluating OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular DegenerationGlobeNewswire
- Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410-Modifier Gene Therapy for Geographic AtrophyGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Ocugen Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Ocugen Inc (OCGN) has a next-year EPS growth estimate of 101.48%, based on analyst consensus.
When was the latest EPS estimate revision for OCGN?▾
The most recent revision occurred on 2026-05-27, when analysts adjusted the next-year EPS growth estimate from 103.69% to 101.48%.
What sector and industry does Ocugen Inc belong to?▾
Ocugen Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. OCGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Ocugen Inc (OCGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports